Compare NEON & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEON | IRIX |
|---|---|---|
| Founded | 1997 | 1989 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1M | 15.0M |
| IPO Year | 1994 | 1996 |
| Metric | NEON | IRIX |
|---|---|---|
| Price | $0.64 | $0.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 50.3K | ★ 702.7K |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.88 | ★ 51.85 |
| EPS | N/A | ★ N/A |
| Revenue | $3,108,000.00 | ★ $41,593,000.00 |
| Revenue This Year | $69.35 | N/A |
| Revenue Next Year | $28.95 | $6.58 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.63 | $0.61 |
| 52 Week High | $2.89 | $1.65 |
| Indicator | NEON | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 27.83 | 43.97 |
| Support Level | N/A | $0.70 |
| Resistance Level | $0.95 | $1.00 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 19.42 | 2.19 |
Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.